SWOG clinical trial number
S1011
A Phase III Surgical Trial to Evaluate The Benefit Of A Standard Versus An Extended Pelvic Lymphadenectomy Performed At Time Of Radical Cystectomy For Muscle Invasive Urothelial Cancer
100% Accrual
Accrual
100%
Closed
Phase
100% Accrual
Accrual
100%
Abbreviated Title
Muscle-Invasive Bladder Ca, Std vs Ext PLND, Ph III
Activated
08/01/2011
Closed
04/15/2017
Participants
Limited: Credentialed Surgeons Listed on S1011 Abstract Page
Research committees
Genitourinary Cancer
Treatment
Surgery
Eligibility Criteria Expand/Collapse
Publication Information Expand/Collapse
Other Clinical Trials
S2312
SWOG Clinical Trial Number
Research Committee(s)
Genitourinary Cancer
Activated
09/03/2024
4% Accrual
Accrual
4%
Open
Phase
S2210
SWOG Clinical Trial Number
Research Committee(s)
Genitourinary Cancer
Activated
08/14/2023
9% Accrual
Accrual
9%
Open
Phase
S2200
SWOG Clinical Trial Number
Research Committee(s)
Genitourinary Cancer
Activated
09/19/2022
16% Accrual
Accrual
16%
Open
Phase